MRNA vs ARGX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jan 22, 2026
MRNA
ARGX
Investment Advisor Scores
ARGX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MRNA | ARGX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 32.4675 | 27.6243 | ARGX |
| PEG Ratio | 0 | 0.8974 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -45.4% | 95.5% | ARGX |
| Earnings Growth | -85.1% | 272.7% | ARGX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 66.2/100 | 55.7/100 | MRNA |
| Profit Margin | -139.6% | 41.6% | ARGX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | HOLD | MRNA |